Literature DB >> 29903352

Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.

Mohamad Alkhouli1, Peter A Noseworthy2, Charanjit S Rihal3, David R Holmes4.   

Abstract

Ischemic stroke in patients with atrial fibrillation is associated with substantial morbidity and mortality. The growing epidemic of atrial fibrillation worldwide has raised concerns about the dire need for effective stroke prevention systems in these patients. Fortunately, the last decade has witnessed a plethora of data on novel stroke prevention methods in patients with nonvalvular atrial fibrillation. However, optimal selection and effective implementation of these preventative strategies require an integrative approach that takes into account not only the available clinical data but also the perspective of each of the stakeholders involved (patient, physician, and society). The goal of this review was to discuss the contemporary issues surrounding stroke prevention in atrial fibrillation from the perspective of these 3 major stakeholders.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; left atrial appendage; non–vitamin K antagonist oral anticoagulant; oral anticoagulation; risk reduction; stroke

Mesh:

Substances:

Year:  2018        PMID: 29903352     DOI: 10.1016/j.jacc.2018.04.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Observed versus Expected Ischemic and Bleeding Events Following Left Atrial Appendage Occlusion.

Authors:  Tatiana Busu; Safi U Khan; Muhammad Alhajji; Fahad Alqahtani; David R Holmes; Mohamad Alkhouli
Journal:  Am J Cardiol       Date:  2020-03-14       Impact factor: 2.778

2.  Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.

Authors:  Mohammed Osman; Tatiana Busu; Khansa Osman; Safi U Khan; Matthew Daniels; David R Holmes; Mohamad Alkhouli
Journal:  JACC Clin Electrophysiol       Date:  2020-01-29

3.  Reader's Comments: Trends in the Utilization of Left Atrial Appendage Exclusion in the United States.

Authors:  Safi U Khan; Muhammad Zia Khan; Mohamad Alkhouli
Journal:  Am J Cardiol       Date:  2020-04-07       Impact factor: 2.778

4.  Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studies.

Authors:  Manuel Anguita; Mariano de la Figuera; Alejandro I Pérez Cabeza; Carmen Suarez Fernández
Journal:  Drugs Context       Date:  2019-10-09

5.  MTHFR Gene Polymorphisms Prevalence and Cardiovascular Risk Factors Involved in Cardioembolic Stroke Type and Severity.

Authors:  Dana Simona Chita; Anca Tudor; Ruxandra Christodorescu; Florina Nicoleta Buleu; Raluca Sosdean; Sanda Maria Deme; Simona Mercea; Adina Pop Moldovan; Ana Maria Pah; Any Docu Axelerad; Daniel Docu Axelerad; Simona Ruxanda Dragan
Journal:  Brain Sci       Date:  2020-07-24

6.  Safety and effects of volume loading during transesophageal echocardiography in the pre-procedural work-up for left atrial appendage closure.

Authors:  Afonso B Freitas-Ferraz; Mathieu Bernier; Kim O'Connor; Jonathan Beaudoin; Jean Champagne; Jean-Michel Paradis; Gilles O'Hara; Guillem Muntané-Carol; Alberto Alperi; Laurent Faroux; Lucia Junquera; Josep Rodés-Cabau
Journal:  Cardiovasc Ultrasound       Date:  2021-01-02       Impact factor: 2.062

7.  Contemporary procedural trends of Watchman percutaneous left atrial appendage occlusion in the United States.

Authors:  Muhammad Bilal Munir; Muhammad Zia Khan; Douglas Darden; Deepak K Pasupula; Sudarshan Balla; Frederick T Han; Ryan Reeves; Jonathan C Hsu
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-11

Review 8.  Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.

Authors:  Michael G Fradley; Theresa M Beckie; Sherry Ann Brown; Richard K Cheng; Susan F Dent; Anju Nohria; Kristen K Patton; Jagmeet P Singh; Brian Olshansky
Journal:  Circulation       Date:  2021-06-17       Impact factor: 29.690

9.  Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting.

Authors:  Yue Wu; Chi Zhang; Zhi-Chun Gu
Journal:  Front Cardiovasc Med       Date:  2021-06-29

Review 10.  Combination of ablation and left atrial appendage closure as "One-stop" procedure in the treatment of atrial fibrillation: Current status and future perspective.

Authors:  Ben He; Li-Sheng Jiang; Zi-Yong Hao; Hao Wang; Yu-Tong Miao
Journal:  Pacing Clin Electrophysiol       Date:  2021-03-09       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.